nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—ABCB1—hematologic cancer	0.135	1	CbGaD
Desloratadine—CYP1A2—Anagrelide—hematologic cancer	0.0357	0.0579	CbGbCtD
Desloratadine—CYP2C9—Bexarotene—hematologic cancer	0.0223	0.0361	CbGbCtD
Desloratadine—ABCB1—Lenalidomide—hematologic cancer	0.0216	0.0351	CbGbCtD
Desloratadine—CYP2D6—Lomustine—hematologic cancer	0.019	0.0307	CbGbCtD
Desloratadine—CYP1A2—Carmustine—hematologic cancer	0.0188	0.0304	CbGbCtD
Desloratadine—CYP2C9—Idarubicin—hematologic cancer	0.0185	0.0299	CbGbCtD
Desloratadine—CYP2D6—Idarubicin—hematologic cancer	0.0169	0.0274	CbGbCtD
Desloratadine—CYP2C19—Bortezomib—hematologic cancer	0.0164	0.0266	CbGbCtD
Desloratadine—CYP1A2—Methoxsalen—hematologic cancer	0.016	0.0258	CbGbCtD
Desloratadine—CYP1A2—Bortezomib—hematologic cancer	0.0152	0.0246	CbGbCtD
Desloratadine—CYP1A2—Daunorubicin—hematologic cancer	0.0145	0.0235	CbGbCtD
Desloratadine—CYP2D6—Hydroxyurea—hematologic cancer	0.0144	0.0233	CbGbCtD
Desloratadine—CYP2C19—Thalidomide—hematologic cancer	0.0143	0.0232	CbGbCtD
Desloratadine—CYP1A2—Alitretinoin—hematologic cancer	0.0142	0.023	CbGbCtD
Desloratadine—CYP2C9—Bortezomib—hematologic cancer	0.0137	0.0222	CbGbCtD
Desloratadine—CYP2C19—Teniposide—hematologic cancer	0.0137	0.0221	CbGbCtD
Desloratadine—CYP1A2—Thalidomide—hematologic cancer	0.0132	0.0214	CbGbCtD
Desloratadine—ABCB1—Daunorubicin—hematologic cancer	0.0127	0.0206	CbGbCtD
Desloratadine—CYP2C19—Ifosfamide—hematologic cancer	0.0126	0.0204	CbGbCtD
Desloratadine—CYP2D6—Bortezomib—hematologic cancer	0.0125	0.0203	CbGbCtD
Desloratadine—ABCB1—Alitretinoin—hematologic cancer	0.0124	0.0201	CbGbCtD
Desloratadine—CYP2C19—Imatinib—hematologic cancer	0.012	0.0195	CbGbCtD
Desloratadine—CYP2C9—Thalidomide—hematologic cancer	0.0119	0.0193	CbGbCtD
Desloratadine—CYP1A2—Dacarbazine—hematologic cancer	0.0114	0.0184	CbGbCtD
Desloratadine—CYP2C9—Teniposide—hematologic cancer	0.0114	0.0184	CbGbCtD
Desloratadine—CYP1A2—Imatinib—hematologic cancer	0.0111	0.018	CbGbCtD
Desloratadine—CYP2C9—Ifosfamide—hematologic cancer	0.0105	0.017	CbGbCtD
Desloratadine—CYP2C9—Imatinib—hematologic cancer	0.01	0.0162	CbGbCtD
Desloratadine—ABCB1—Imatinib—hematologic cancer	0.00972	0.0157	CbGbCtD
Desloratadine—CYP2D6—Imatinib—hematologic cancer	0.00916	0.0148	CbGbCtD
Desloratadine—CYP2C9—Nilotinib—hematologic cancer	0.0091	0.0147	CbGbCtD
Desloratadine—CYP1A2—Dasatinib—hematologic cancer	0.00893	0.0145	CbGbCtD
Desloratadine—ABCB1—Nilotinib—hematologic cancer	0.00883	0.0143	CbGbCtD
Desloratadine—ABCB1—Vinorelbine—hematologic cancer	0.00876	0.0142	CbGbCtD
Desloratadine—CYP2D6—Nilotinib—hematologic cancer	0.00832	0.0135	CbGbCtD
Desloratadine—CYP2D6—Vinorelbine—hematologic cancer	0.00825	0.0134	CbGbCtD
Desloratadine—CYP2C19—Prednisone—hematologic cancer	0.00794	0.0129	CbGbCtD
Desloratadine—ABCB1—Dasatinib—hematologic cancer	0.00781	0.0126	CbGbCtD
Desloratadine—ABCB1—Mitoxantrone—hematologic cancer	0.00771	0.0125	CbGbCtD
Desloratadine—ABCB1—Betamethasone—hematologic cancer	0.00687	0.0111	CbGbCtD
Desloratadine—ABCB1—Gemcitabine—hematologic cancer	0.00681	0.011	CbGbCtD
Desloratadine—ABCB1—Prednisolone—hematologic cancer	0.00678	0.011	CbGbCtD
Desloratadine—ABCB1—Prednisone—hematologic cancer	0.0064	0.0104	CbGbCtD
Desloratadine—ABCB1—Irinotecan—hematologic cancer	0.00607	0.00984	CbGbCtD
Desloratadine—CYP1A2—Etoposide—hematologic cancer	0.00556	0.00901	CbGbCtD
Desloratadine—ABCB1—Vinblastine—hematologic cancer	0.0054	0.00875	CbGbCtD
Desloratadine—ABCB1—Vincristine—hematologic cancer	0.00531	0.0086	CbGbCtD
Desloratadine—CYP2C9—Cisplatin—hematologic cancer	0.0051	0.00826	CbGbCtD
Desloratadine—CYP2D6—Vinblastine—hematologic cancer	0.00509	0.00824	CbGbCtD
Desloratadine—CYP2C19—Dexamethasone—hematologic cancer	0.00495	0.00803	CbGbCtD
Desloratadine—ABCB1—Cisplatin—hematologic cancer	0.00495	0.00802	CbGbCtD
Desloratadine—ABCB1—Etoposide—hematologic cancer	0.00486	0.00788	CbGbCtD
Desloratadine—CYP2C9—Dexamethasone—hematologic cancer	0.00412	0.00668	CbGbCtD
Desloratadine—ABCB1—Dexamethasone—hematologic cancer	0.004	0.00648	CbGbCtD
Desloratadine—CYP2D6—Dexamethasone—hematologic cancer	0.00377	0.0061	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—hematologic cancer	0.00332	0.00537	CbGbCtD
Desloratadine—ABCB1—Methotrexate—hematologic cancer	0.00321	0.00521	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—hematologic cancer	0.00313	0.00506	CbGbCtD
Desloratadine—Angioedema—Prednisone—hematologic cancer	5.91e-05	0.000282	CcSEcCtD
Desloratadine—Diarrhoea—Gemcitabine—hematologic cancer	5.9e-05	0.000281	CcSEcCtD
Desloratadine—Nausea—Thalidomide—hematologic cancer	5.89e-05	0.000281	CcSEcCtD
Desloratadine—Dyspepsia—Triamcinolone—hematologic cancer	5.88e-05	0.00028	CcSEcCtD
Desloratadine—Rash—Ifosfamide—hematologic cancer	5.88e-05	0.00028	CcSEcCtD
Desloratadine—Dermatitis—Ifosfamide—hematologic cancer	5.88e-05	0.00028	CcSEcCtD
Desloratadine—Dizziness—Irinotecan—hematologic cancer	5.86e-05	0.000279	CcSEcCtD
Desloratadine—Urticaria—Etoposide—hematologic cancer	5.85e-05	0.000279	CcSEcCtD
Desloratadine—Abdominal pain—Etoposide—hematologic cancer	5.83e-05	0.000277	CcSEcCtD
Desloratadine—Body temperature increased—Etoposide—hematologic cancer	5.83e-05	0.000277	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—hematologic cancer	5.83e-05	0.000277	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—hematologic cancer	5.81e-05	0.000277	CcSEcCtD
Desloratadine—Vomiting—Vincristine—hematologic cancer	5.78e-05	0.000275	CcSEcCtD
Desloratadine—Anorexia—Dexamethasone—hematologic cancer	5.78e-05	0.000275	CcSEcCtD
Desloratadine—Anorexia—Betamethasone—hematologic cancer	5.78e-05	0.000275	CcSEcCtD
Desloratadine—Urticaria—Prednisolone—hematologic cancer	5.77e-05	0.000275	CcSEcCtD
Desloratadine—Asthenia—Cisplatin—hematologic cancer	5.77e-05	0.000275	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—hematologic cancer	5.77e-05	0.000275	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—hematologic cancer	5.77e-05	0.000275	CcSEcCtD
Desloratadine—Fatigue—Triamcinolone—hematologic cancer	5.76e-05	0.000274	CcSEcCtD
Desloratadine—Rash—Vincristine—hematologic cancer	5.74e-05	0.000273	CcSEcCtD
Desloratadine—Dermatitis—Vincristine—hematologic cancer	5.73e-05	0.000273	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—hematologic cancer	5.71e-05	0.000272	CcSEcCtD
Desloratadine—Headache—Vincristine—hematologic cancer	5.7e-05	0.000271	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—hematologic cancer	5.67e-05	0.00027	CcSEcCtD
Desloratadine—Nausea—Carmustine—hematologic cancer	5.66e-05	0.000269	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—hematologic cancer	5.65e-05	0.000269	CcSEcCtD
Desloratadine—Vomiting—Mitoxantrone—hematologic cancer	5.63e-05	0.000268	CcSEcCtD
Desloratadine—Vomiting—Irinotecan—hematologic cancer	5.63e-05	0.000268	CcSEcCtD
Desloratadine—Nausea—Alitretinoin—hematologic cancer	5.61e-05	0.000267	CcSEcCtD
Desloratadine—Convulsion—Prednisone—hematologic cancer	5.61e-05	0.000267	CcSEcCtD
Desloratadine—Rash—Mitoxantrone—hematologic cancer	5.59e-05	0.000266	CcSEcCtD
Desloratadine—Rash—Irinotecan—hematologic cancer	5.59e-05	0.000266	CcSEcCtD
Desloratadine—Dermatitis—Mitoxantrone—hematologic cancer	5.58e-05	0.000266	CcSEcCtD
Desloratadine—Dermatitis—Irinotecan—hematologic cancer	5.58e-05	0.000266	CcSEcCtD
Desloratadine—Headache—Mitoxantrone—hematologic cancer	5.55e-05	0.000264	CcSEcCtD
Desloratadine—Headache—Irinotecan—hematologic cancer	5.55e-05	0.000264	CcSEcCtD
Desloratadine—Nausea—Ifosfamide—hematologic cancer	5.54e-05	0.000264	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.53e-05	0.000263	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.53e-05	0.000263	CcSEcCtD
Desloratadine—Myalgia—Prednisone—hematologic cancer	5.51e-05	0.000262	CcSEcCtD
Desloratadine—Diarrhoea—Cisplatin—hematologic cancer	5.5e-05	0.000262	CcSEcCtD
Desloratadine—Vomiting—Gemcitabine—hematologic cancer	5.49e-05	0.000261	CcSEcCtD
Desloratadine—Insomnia—Betamethasone—hematologic cancer	5.49e-05	0.000261	CcSEcCtD
Desloratadine—Insomnia—Dexamethasone—hematologic cancer	5.49e-05	0.000261	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—hematologic cancer	5.44e-05	0.000259	CcSEcCtD
Desloratadine—Rash—Gemcitabine—hematologic cancer	5.44e-05	0.000259	CcSEcCtD
Desloratadine—Dermatitis—Gemcitabine—hematologic cancer	5.44e-05	0.000259	CcSEcCtD
Desloratadine—Hypersensitivity—Etoposide—hematologic cancer	5.43e-05	0.000258	CcSEcCtD
Desloratadine—Erythema—Methotrexate—hematologic cancer	5.41e-05	0.000257	CcSEcCtD
Desloratadine—Headache—Gemcitabine—hematologic cancer	5.41e-05	0.000257	CcSEcCtD
Desloratadine—Nausea—Vincristine—hematologic cancer	5.4e-05	0.000257	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—hematologic cancer	5.4e-05	0.000257	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—hematologic cancer	5.38e-05	0.000256	CcSEcCtD
Desloratadine—Hypersensitivity—Prednisolone—hematologic cancer	5.36e-05	0.000255	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—hematologic cancer	5.34e-05	0.000254	CcSEcCtD
Desloratadine—Dyspepsia—Betamethasone—hematologic cancer	5.34e-05	0.000254	CcSEcCtD
Desloratadine—Dyspepsia—Dexamethasone—hematologic cancer	5.34e-05	0.000254	CcSEcCtD
Desloratadine—Urticaria—Triamcinolone—hematologic cancer	5.31e-05	0.000253	CcSEcCtD
Desloratadine—Asthenia—Etoposide—hematologic cancer	5.29e-05	0.000252	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—hematologic cancer	5.29e-05	0.000252	CcSEcCtD
Desloratadine—Body temperature increased—Triamcinolone—hematologic cancer	5.28e-05	0.000252	CcSEcCtD
Desloratadine—Oedema—Prednisone—hematologic cancer	5.28e-05	0.000251	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisone—hematologic cancer	5.28e-05	0.000251	CcSEcCtD
Desloratadine—Decreased appetite—Dexamethasone—hematologic cancer	5.27e-05	0.000251	CcSEcCtD
Desloratadine—Decreased appetite—Betamethasone—hematologic cancer	5.27e-05	0.000251	CcSEcCtD
Desloratadine—Nausea—Mitoxantrone—hematologic cancer	5.26e-05	0.000251	CcSEcCtD
Desloratadine—Nausea—Irinotecan—hematologic cancer	5.26e-05	0.000251	CcSEcCtD
Desloratadine—Infection—Prednisone—hematologic cancer	5.25e-05	0.00025	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.24e-05	0.000249	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.24e-05	0.000249	CcSEcCtD
Desloratadine—Fatigue—Betamethasone—hematologic cancer	5.23e-05	0.000249	CcSEcCtD
Desloratadine—Fatigue—Dexamethasone—hematologic cancer	5.23e-05	0.000249	CcSEcCtD
Desloratadine—Pruritus—Etoposide—hematologic cancer	5.21e-05	0.000248	CcSEcCtD
Desloratadine—Nervous system disorder—Prednisone—hematologic cancer	5.18e-05	0.000247	CcSEcCtD
Desloratadine—Tachycardia—Prednisone—hematologic cancer	5.15e-05	0.000245	CcSEcCtD
Desloratadine—Nausea—Gemcitabine—hematologic cancer	5.13e-05	0.000244	CcSEcCtD
Desloratadine—Vomiting—Cisplatin—hematologic cancer	5.11e-05	0.000243	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—hematologic cancer	5.09e-05	0.000243	CcSEcCtD
Desloratadine—Rash—Cisplatin—hematologic cancer	5.07e-05	0.000241	CcSEcCtD
Desloratadine—Dermatitis—Cisplatin—hematologic cancer	5.07e-05	0.000241	CcSEcCtD
Desloratadine—Erythema—Epirubicin—hematologic cancer	5.06e-05	0.000241	CcSEcCtD
Desloratadine—Diarrhoea—Etoposide—hematologic cancer	5.04e-05	0.00024	CcSEcCtD
Desloratadine—Anorexia—Prednisone—hematologic cancer	5.03e-05	0.00024	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—hematologic cancer	4.99e-05	0.000238	CcSEcCtD
Desloratadine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.96e-05	0.000236	CcSEcCtD
Desloratadine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.96e-05	0.000236	CcSEcCtD
Desloratadine—Hypersensitivity—Triamcinolone—hematologic cancer	4.92e-05	0.000234	CcSEcCtD
Desloratadine—Dizziness—Etoposide—hematologic cancer	4.87e-05	0.000232	CcSEcCtD
Desloratadine—Urticaria—Betamethasone—hematologic cancer	4.82e-05	0.000229	CcSEcCtD
Desloratadine—Urticaria—Dexamethasone—hematologic cancer	4.82e-05	0.000229	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.81e-05	0.000229	CcSEcCtD
Desloratadine—Dizziness—Prednisolone—hematologic cancer	4.81e-05	0.000229	CcSEcCtD
Desloratadine—Asthenia—Triamcinolone—hematologic cancer	4.8e-05	0.000228	CcSEcCtD
Desloratadine—Body temperature increased—Betamethasone—hematologic cancer	4.79e-05	0.000228	CcSEcCtD
Desloratadine—Body temperature increased—Dexamethasone—hematologic cancer	4.79e-05	0.000228	CcSEcCtD
Desloratadine—Abdominal pain—Dexamethasone—hematologic cancer	4.79e-05	0.000228	CcSEcCtD
Desloratadine—Abdominal pain—Betamethasone—hematologic cancer	4.79e-05	0.000228	CcSEcCtD
Desloratadine—Nausea—Cisplatin—hematologic cancer	4.78e-05	0.000227	CcSEcCtD
Desloratadine—Insomnia—Prednisone—hematologic cancer	4.78e-05	0.000227	CcSEcCtD
Desloratadine—Pruritus—Triamcinolone—hematologic cancer	4.73e-05	0.000225	CcSEcCtD
Desloratadine—Cough—Methotrexate—hematologic cancer	4.72e-05	0.000225	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—hematologic cancer	4.71e-05	0.000224	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—hematologic cancer	4.69e-05	0.000223	CcSEcCtD
Desloratadine—Vomiting—Etoposide—hematologic cancer	4.69e-05	0.000223	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—hematologic cancer	4.68e-05	0.000223	CcSEcCtD
Desloratadine—Agitation—Epirubicin—hematologic cancer	4.65e-05	0.000221	CcSEcCtD
Desloratadine—Dyspepsia—Prednisone—hematologic cancer	4.65e-05	0.000221	CcSEcCtD
Desloratadine—Rash—Etoposide—hematologic cancer	4.65e-05	0.000221	CcSEcCtD
Desloratadine—Dermatitis—Etoposide—hematologic cancer	4.64e-05	0.000221	CcSEcCtD
Desloratadine—Headache—Etoposide—hematologic cancer	4.62e-05	0.00022	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—hematologic cancer	4.6e-05	0.000219	CcSEcCtD
Desloratadine—Decreased appetite—Prednisone—hematologic cancer	4.59e-05	0.000219	CcSEcCtD
Desloratadine—Rash—Prednisolone—hematologic cancer	4.58e-05	0.000218	CcSEcCtD
Desloratadine—Dermatitis—Prednisolone—hematologic cancer	4.58e-05	0.000218	CcSEcCtD
Desloratadine—Fatigue—Prednisone—hematologic cancer	4.55e-05	0.000217	CcSEcCtD
Desloratadine—Headache—Prednisolone—hematologic cancer	4.55e-05	0.000217	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—hematologic cancer	4.47e-05	0.000213	CcSEcCtD
Desloratadine—Dizziness—Triamcinolone—hematologic cancer	4.42e-05	0.00021	CcSEcCtD
Desloratadine—Cough—Epirubicin—hematologic cancer	4.42e-05	0.00021	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—hematologic cancer	4.41e-05	0.00021	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—hematologic cancer	4.39e-05	0.000209	CcSEcCtD
Desloratadine—Infection—Methotrexate—hematologic cancer	4.39e-05	0.000209	CcSEcCtD
Desloratadine—Nausea—Etoposide—hematologic cancer	4.38e-05	0.000208	CcSEcCtD
Desloratadine—Asthenia—Dexamethasone—hematologic cancer	4.35e-05	0.000207	CcSEcCtD
Desloratadine—Asthenia—Betamethasone—hematologic cancer	4.35e-05	0.000207	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—hematologic cancer	4.33e-05	0.000206	CcSEcCtD
Desloratadine—Gastrointestinal pain—Prednisone—hematologic cancer	4.32e-05	0.000206	CcSEcCtD
Desloratadine—Nausea—Prednisolone—hematologic cancer	4.32e-05	0.000206	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—hematologic cancer	4.31e-05	0.000205	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—hematologic cancer	4.3e-05	0.000205	CcSEcCtD
Desloratadine—Pruritus—Dexamethasone—hematologic cancer	4.29e-05	0.000204	CcSEcCtD
Desloratadine—Pruritus—Betamethasone—hematologic cancer	4.29e-05	0.000204	CcSEcCtD
Desloratadine—Vomiting—Triamcinolone—hematologic cancer	4.25e-05	0.000202	CcSEcCtD
Desloratadine—Rash—Triamcinolone—hematologic cancer	4.21e-05	0.000201	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—hematologic cancer	4.21e-05	0.000201	CcSEcCtD
Desloratadine—Dermatitis—Triamcinolone—hematologic cancer	4.21e-05	0.0002	CcSEcCtD
Desloratadine—Anorexia—Methotrexate—hematologic cancer	4.21e-05	0.0002	CcSEcCtD
Desloratadine—Urticaria—Prednisone—hematologic cancer	4.2e-05	0.0002	CcSEcCtD
Desloratadine—Headache—Triamcinolone—hematologic cancer	4.19e-05	0.000199	CcSEcCtD
Desloratadine—Abdominal pain—Prednisone—hematologic cancer	4.18e-05	0.000199	CcSEcCtD
Desloratadine—Body temperature increased—Prednisone—hematologic cancer	4.18e-05	0.000199	CcSEcCtD
Desloratadine—Diarrhoea—Betamethasone—hematologic cancer	4.15e-05	0.000198	CcSEcCtD
Desloratadine—Diarrhoea—Dexamethasone—hematologic cancer	4.15e-05	0.000198	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—hematologic cancer	4.14e-05	0.000197	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—hematologic cancer	4.13e-05	0.000197	CcSEcCtD
Desloratadine—Oedema—Epirubicin—hematologic cancer	4.13e-05	0.000197	CcSEcCtD
Desloratadine—Infection—Epirubicin—hematologic cancer	4.1e-05	0.000195	CcSEcCtD
Desloratadine—Cough—Doxorubicin—hematologic cancer	4.09e-05	0.000195	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—hematologic cancer	4.06e-05	0.000193	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—hematologic cancer	4.05e-05	0.000193	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—hematologic cancer	4.03e-05	0.000192	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.02e-05	0.000191	CcSEcCtD
Desloratadine—Dizziness—Dexamethasone—hematologic cancer	4.01e-05	0.000191	CcSEcCtD
Desloratadine—Dizziness—Betamethasone—hematologic cancer	4.01e-05	0.000191	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—hematologic cancer	3.99e-05	0.00019	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—hematologic cancer	3.99e-05	0.00019	CcSEcCtD
Desloratadine—Nausea—Triamcinolone—hematologic cancer	3.97e-05	0.000189	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—hematologic cancer	3.94e-05	0.000187	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—hematologic cancer	3.94e-05	0.000187	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—hematologic cancer	3.92e-05	0.000187	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—hematologic cancer	3.9e-05	0.000186	CcSEcCtD
Desloratadine—Hypersensitivity—Prednisone—hematologic cancer	3.89e-05	0.000185	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—hematologic cancer	3.89e-05	0.000185	CcSEcCtD
Desloratadine—Vomiting—Dexamethasone—hematologic cancer	3.86e-05	0.000184	CcSEcCtD
Desloratadine—Vomiting—Betamethasone—hematologic cancer	3.86e-05	0.000184	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—hematologic cancer	3.84e-05	0.000183	CcSEcCtD
Desloratadine—Rash—Dexamethasone—hematologic cancer	3.82e-05	0.000182	CcSEcCtD
Desloratadine—Rash—Betamethasone—hematologic cancer	3.82e-05	0.000182	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.82e-05	0.000182	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—hematologic cancer	3.82e-05	0.000182	CcSEcCtD
Desloratadine—Dermatitis—Dexamethasone—hematologic cancer	3.82e-05	0.000182	CcSEcCtD
Desloratadine—Dermatitis—Betamethasone—hematologic cancer	3.82e-05	0.000182	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.81e-05	0.000181	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—hematologic cancer	3.81e-05	0.000181	CcSEcCtD
Desloratadine—Headache—Betamethasone—hematologic cancer	3.8e-05	0.000181	CcSEcCtD
Desloratadine—Headache—Dexamethasone—hematologic cancer	3.8e-05	0.000181	CcSEcCtD
Desloratadine—Infection—Doxorubicin—hematologic cancer	3.8e-05	0.000181	CcSEcCtD
Desloratadine—Asthenia—Prednisone—hematologic cancer	3.79e-05	0.00018	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.76e-05	0.000179	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—hematologic cancer	3.75e-05	0.000178	CcSEcCtD
Desloratadine—Pruritus—Prednisone—hematologic cancer	3.74e-05	0.000178	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—hematologic cancer	3.74e-05	0.000178	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—hematologic cancer	3.73e-05	0.000178	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—hematologic cancer	3.68e-05	0.000175	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—hematologic cancer	3.67e-05	0.000175	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—hematologic cancer	3.64e-05	0.000173	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—hematologic cancer	3.64e-05	0.000173	CcSEcCtD
Desloratadine—Diarrhoea—Prednisone—hematologic cancer	3.61e-05	0.000172	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.61e-05	0.000172	CcSEcCtD
Desloratadine—Nausea—Dexamethasone—hematologic cancer	3.6e-05	0.000171	CcSEcCtD
Desloratadine—Nausea—Betamethasone—hematologic cancer	3.6e-05	0.000171	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—hematologic cancer	3.59e-05	0.000171	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.57e-05	0.00017	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—hematologic cancer	3.56e-05	0.00017	CcSEcCtD
Desloratadine—Urticaria—Methotrexate—hematologic cancer	3.51e-05	0.000167	CcSEcCtD
Desloratadine—Dizziness—Prednisone—hematologic cancer	3.49e-05	0.000166	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—hematologic cancer	3.49e-05	0.000166	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—hematologic cancer	3.49e-05	0.000166	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.48e-05	0.000166	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—hematologic cancer	3.46e-05	0.000165	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—hematologic cancer	3.41e-05	0.000162	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—hematologic cancer	3.4e-05	0.000162	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.38e-05	0.000161	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—hematologic cancer	3.36e-05	0.00016	CcSEcCtD
Desloratadine—Vomiting—Prednisone—hematologic cancer	3.36e-05	0.00016	CcSEcCtD
Desloratadine—Rash—Prednisone—hematologic cancer	3.33e-05	0.000159	CcSEcCtD
Desloratadine—Dermatitis—Prednisone—hematologic cancer	3.33e-05	0.000158	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—hematologic cancer	3.32e-05	0.000158	CcSEcCtD
Desloratadine—Headache—Prednisone—hematologic cancer	3.31e-05	0.000158	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.3e-05	0.000157	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—hematologic cancer	3.3e-05	0.000157	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—hematologic cancer	3.28e-05	0.000156	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—hematologic cancer	3.27e-05	0.000155	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—hematologic cancer	3.27e-05	0.000155	CcSEcCtD
Desloratadine—Hypersensitivity—Methotrexate—hematologic cancer	3.25e-05	0.000155	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—hematologic cancer	3.17e-05	0.000151	CcSEcCtD
Desloratadine—Nausea—Prednisone—hematologic cancer	3.14e-05	0.000149	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.13e-05	0.000149	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—hematologic cancer	3.12e-05	0.000149	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—hematologic cancer	3.04e-05	0.000145	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—hematologic cancer	3.04e-05	0.000145	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—hematologic cancer	3.02e-05	0.000144	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—hematologic cancer	3.02e-05	0.000144	CcSEcCtD
Desloratadine—Diarrhoea—Methotrexate—hematologic cancer	3.02e-05	0.000144	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—hematologic cancer	2.96e-05	0.000141	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—hematologic cancer	2.92e-05	0.000139	CcSEcCtD
Desloratadine—Dizziness—Methotrexate—hematologic cancer	2.92e-05	0.000139	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—hematologic cancer	2.83e-05	0.000135	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—hematologic cancer	2.82e-05	0.000134	CcSEcCtD
Desloratadine—Vomiting—Methotrexate—hematologic cancer	2.81e-05	0.000134	CcSEcCtD
Desloratadine—Rash—Methotrexate—hematologic cancer	2.78e-05	0.000132	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—hematologic cancer	2.78e-05	0.000132	CcSEcCtD
Desloratadine—Headache—Methotrexate—hematologic cancer	2.77e-05	0.000132	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—hematologic cancer	2.74e-05	0.000131	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—hematologic cancer	2.73e-05	0.00013	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—hematologic cancer	2.7e-05	0.000129	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—hematologic cancer	2.63e-05	0.000125	CcSEcCtD
Desloratadine—Nausea—Methotrexate—hematologic cancer	2.62e-05	0.000125	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—hematologic cancer	2.62e-05	0.000124	CcSEcCtD
Desloratadine—Rash—Epirubicin—hematologic cancer	2.6e-05	0.000124	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—hematologic cancer	2.6e-05	0.000124	CcSEcCtD
Desloratadine—Headache—Epirubicin—hematologic cancer	2.59e-05	0.000123	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—hematologic cancer	2.53e-05	0.00012	CcSEcCtD
Desloratadine—Nausea—Epirubicin—hematologic cancer	2.45e-05	0.000117	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—hematologic cancer	2.43e-05	0.000116	CcSEcCtD
Desloratadine—Rash—Doxorubicin—hematologic cancer	2.41e-05	0.000115	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—hematologic cancer	2.41e-05	0.000115	CcSEcCtD
Desloratadine—Headache—Doxorubicin—hematologic cancer	2.39e-05	0.000114	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—hematologic cancer	2.27e-05	0.000108	CcSEcCtD
Desloratadine—ABCB1—Metabolism—ENO2—hematologic cancer	6.54e-06	0.000172	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCC3—hematologic cancer	6.53e-06	0.000171	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TXN—hematologic cancer	6.53e-06	0.000171	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.53e-06	0.000171	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	6.52e-06	0.000171	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTT1—hematologic cancer	6.49e-06	0.000171	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.46e-06	0.00017	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.46e-06	0.00017	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NUP214—hematologic cancer	6.41e-06	0.000168	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CREB1—hematologic cancer	6.41e-06	0.000168	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.4e-06	0.000168	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.4e-06	0.000168	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.39e-06	0.000168	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.39e-06	0.000168	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NUP214—hematologic cancer	6.35e-06	0.000167	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SDC1—hematologic cancer	6.35e-06	0.000167	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTT1—hematologic cancer	6.34e-06	0.000167	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT1—hematologic cancer	6.33e-06	0.000166	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.29e-06	0.000165	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.28e-06	0.000165	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MTR—hematologic cancer	6.28e-06	0.000165	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCL2—hematologic cancer	6.27e-06	0.000165	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6R—hematologic cancer	6.25e-06	0.000164	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MTR—hematologic cancer	6.23e-06	0.000164	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.23e-06	0.000164	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SDC1—hematologic cancer	6.2e-06	0.000163	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ENO2—hematologic cancer	6.16e-06	0.000162	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	6.15e-06	0.000162	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.15e-06	0.000162	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.14e-06	0.000161	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ENO2—hematologic cancer	6.11e-06	0.00016	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.06e-06	0.000159	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.99e-06	0.000157	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	5.98e-06	0.000157	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.97e-06	0.000157	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.97e-06	0.000157	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.97e-06	0.000157	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	5.96e-06	0.000156	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.93e-06	0.000156	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GRB2—hematologic cancer	5.93e-06	0.000156	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.92e-06	0.000156	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	5.92e-06	0.000155	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	5.91e-06	0.000155	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SDC1—hematologic cancer	5.84e-06	0.000153	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.83e-06	0.000153	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KITLG—hematologic cancer	5.83e-06	0.000153	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.82e-06	0.000153	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SDC1—hematologic cancer	5.79e-06	0.000152	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.73e-06	0.00015	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	5.7e-06	0.00015	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	5.68e-06	0.000149	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	5.65e-06	0.000148	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NUP98—hematologic cancer	5.63e-06	0.000148	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	5.59e-06	0.000147	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.56e-06	0.000146	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.53e-06	0.000145	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.47e-06	0.000144	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.47e-06	0.000144	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CD86—hematologic cancer	5.46e-06	0.000143	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.46e-06	0.000143	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	5.43e-06	0.000143	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NUP214—hematologic cancer	5.43e-06	0.000143	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CD44—hematologic cancer	5.4e-06	0.000142	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NQO1—hematologic cancer	5.4e-06	0.000142	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HES1—hematologic cancer	5.39e-06	0.000141	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.37e-06	0.000141	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	5.36e-06	0.000141	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.32e-06	0.00014	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MTR—hematologic cancer	5.32e-06	0.00014	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGF1—hematologic cancer	5.3e-06	0.000139	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CSF2—hematologic cancer	5.3e-06	0.000139	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.29e-06	0.000139	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NQO1—hematologic cancer	5.27e-06	0.000138	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CD44—hematologic cancer	5.27e-06	0.000138	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.22e-06	0.000137	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	5.22e-06	0.000137	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ENO2—hematologic cancer	5.22e-06	0.000137	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	5.22e-06	0.000137	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	5.21e-06	0.000137	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	5.16e-06	0.000135	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	5.13e-06	0.000135	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JAK1—hematologic cancer	5.11e-06	0.000134	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	5.11e-06	0.000134	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYCS—hematologic cancer	5.11e-06	0.000134	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.07e-06	0.000133	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.06e-06	0.000133	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYCS—hematologic cancer	4.98e-06	0.000131	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.98e-06	0.000131	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NQO1—hematologic cancer	4.96e-06	0.00013	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CD44—hematologic cancer	4.96e-06	0.00013	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.95e-06	0.00013	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SDC1—hematologic cancer	4.95e-06	0.00013	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CD44—hematologic cancer	4.92e-06	0.000129	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NQO1—hematologic cancer	4.92e-06	0.000129	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.82e-06	0.000127	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	4.77e-06	0.000125	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—hematologic cancer	4.74e-06	0.000124	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.72e-06	0.000124	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TERT—hematologic cancer	4.72e-06	0.000124	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYCS—hematologic cancer	4.7e-06	0.000123	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.67e-06	0.000123	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.66e-06	0.000123	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYCS—hematologic cancer	4.66e-06	0.000122	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.63e-06	0.000122	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	4.61e-06	0.000121	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.57e-06	0.00012	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TSC2—hematologic cancer	4.5e-06	0.000118	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.5e-06	0.000118	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.46e-06	0.000117	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—hematologic cancer	4.39e-06	0.000115	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.36e-06	0.000114	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	4.33e-06	0.000114	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	4.29e-06	0.000113	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.26e-06	0.000112	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ESR1—hematologic cancer	4.21e-06	0.000111	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NQO1—hematologic cancer	4.21e-06	0.00011	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CD44—hematologic cancer	4.21e-06	0.00011	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.16e-06	0.000109	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FN1—hematologic cancer	4.16e-06	0.000109	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.14e-06	0.000109	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.14e-06	0.000109	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.14e-06	0.000109	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.12e-06	0.000108	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BAD—hematologic cancer	4.11e-06	0.000108	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	4.11e-06	0.000108	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.1e-06	0.000108	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	4.07e-06	0.000107	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—hematologic cancer	4.04e-06	0.000106	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NCOR1—hematologic cancer	4.04e-06	0.000106	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CD80—hematologic cancer	3.98e-06	0.000105	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYCS—hematologic cancer	3.98e-06	0.000105	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	3.98e-06	0.000104	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KIT—hematologic cancer	3.98e-06	0.000104	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	3.98e-06	0.000104	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.97e-06	0.000104	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.95e-06	0.000104	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.92e-06	0.000103	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	3.91e-06	0.000103	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.89e-06	0.000102	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	3.81e-06	0.0001	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.8e-06	0.0001	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.8e-06	0.0001	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CREB1—hematologic cancer	3.79e-06	9.94e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.77e-06	9.91e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.77e-06	9.91e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BRAF—hematologic cancer	3.74e-06	9.82e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCL2—hematologic cancer	3.7e-06	9.73e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6R—hematologic cancer	3.69e-06	9.7e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	3.69e-06	9.68e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.66e-06	9.6e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MTHFR—hematologic cancer	3.57e-06	9.37e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.56e-06	9.35e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	3.52e-06	9.24e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.51e-06	9.21e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	3.5e-06	9.18e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.46e-06	9.1e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	3.42e-06	8.99e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.39e-06	8.91e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.36e-06	8.83e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGF2—hematologic cancer	3.35e-06	8.79e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.33e-06	8.76e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.32e-06	8.72e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	3.3e-06	8.67e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.22e-06	8.47e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.22e-06	8.47e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.22e-06	8.46e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JAK2—hematologic cancer	3.21e-06	8.43e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	3.14e-06	8.26e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MDM2—hematologic cancer	3.13e-06	8.23e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.07e-06	8.07e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MTOR—hematologic cancer	3.05e-06	8e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	3.05e-06	8e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—hematologic cancer	3e-06	7.88e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.94e-06	7.72e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	2.91e-06	7.64e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	2.86e-06	7.51e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.85e-06	7.48e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.85e-06	7.48e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	2.83e-06	7.43e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.83e-06	7.42e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP3—hematologic cancer	2.8e-06	7.36e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.8e-06	7.36e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—hematologic cancer	2.8e-06	7.35e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—hematologic cancer	2.78e-06	7.31e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CREBBP—hematologic cancer	2.78e-06	7.3e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—hematologic cancer	2.73e-06	7.17e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JUN—hematologic cancer	2.72e-06	7.15e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.7e-06	7.09e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALB—hematologic cancer	2.67e-06	7e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	2.64e-06	6.93e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.64e-06	6.92e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—hematologic cancer	2.63e-06	6.92e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.62e-06	6.88e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALB—hematologic cancer	2.6e-06	6.84e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.6e-06	6.82e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	2.58e-06	6.77e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	2.57e-06	6.75e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.55e-06	6.7e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EP300—hematologic cancer	2.51e-06	6.6e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.51e-06	6.59e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.49e-06	6.54e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.48e-06	6.52e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.46e-06	6.47e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALB—hematologic cancer	2.45e-06	6.44e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SRC—hematologic cancer	2.44e-06	6.41e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALB—hematologic cancer	2.43e-06	6.39e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.39e-06	6.29e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	2.38e-06	6.25e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—hematologic cancer	2.35e-06	6.19e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.35e-06	6.18e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NRAS—hematologic cancer	2.35e-06	6.17e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.35e-06	6.16e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.33e-06	6.11e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.3e-06	6.03e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	2.25e-06	5.91e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.22e-06	5.83e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—hematologic cancer	2.19e-06	5.75e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	2.18e-06	5.73e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.16e-06	5.69e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.15e-06	5.64e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.1e-06	5.53e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALB—hematologic cancer	2.08e-06	5.46e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.03e-06	5.34e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—hematologic cancer	2.02e-06	5.31e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.99e-06	5.22e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—hematologic cancer	1.99e-06	5.21e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—EP300—hematologic cancer	1.94e-06	5.1e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—EP300—hematologic cancer	1.89e-06	4.97e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.87e-06	4.91e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.86e-06	4.88e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.85e-06	4.87e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.83e-06	4.82e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.8e-06	4.72e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—EP300—hematologic cancer	1.78e-06	4.69e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—EP300—hematologic cancer	1.77e-06	4.65e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.72e-06	4.51e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.64e-06	4.32e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.58e-06	4.16e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.52e-06	3.99e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—EP300—hematologic cancer	1.51e-06	3.97e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.43e-06	3.77e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.4e-06	3.68e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.32e-06	3.47e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.31e-06	3.44e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.17e-06	3.08e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—hematologic cancer	1.14e-06	3.01e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.12e-06	2.94e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.08e-06	2.83e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.07e-06	2.81e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—hematologic cancer	9.13e-07	2.4e-05	CbGpPWpGaD
